Home › Cardiovascular Disease › California › Concord
Cardiovascular Disease clinical trials in Concord, CA
4 studies for Cardiovascular Disease are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- John Muir Physician Network Clinical Research Center, Concord
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- John Muir Medical Center - Concord Campus, Concord
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Walnut Creek · 5 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Diablo Clinical Research, Walnut Creek · 5 mi away
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
Other studies in Concord
- Obesity18 studies
- Overweight16 studies
- Non-Small Cell Lung Cancer14 studies
- Major Depressive Disorder12 studies
- Type 2 Diabetes10 studies
- Breast Cancer8 studies
- Migraine8 studies
- Lung Cancer8 studies
- Cancer (all types)7 studies
- Depression6 studies
- Diabetes5 studies
- High Blood Pressure5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.